Slingshot members are tracking this event:
Phase 2/3 data of Biohaven's (BHVN) TRORILUZOLE in Generalized anxiety disorder (GAD) due early-1Q 2020
Slingshot Insights Explained
Feb 10, 2020
Don’t see a project related to the catalyst you care about?
Related Keywords Troriluzole, Anxiety Disorders, Generalized Anxiety Disorder